Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice - PubMed (original) (raw)
. 2008 Jun;57(6):1470-81.
doi: 10.2337/db07-1403. Epub 2008 Feb 27.
Affiliations
- PMID: 18305141
- DOI: 10.2337/db07-1403
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Patrice D Cani et al. Diabetes. 2008 Jun.
Abstract
Objective: Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases.
Research design and methods: We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect.
Results: We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat-fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14(-)(/)(-) mutant mice mimicked the metabolic and inflammatory effects of antibiotics.
Conclusions: This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Similar articles
- Metabolic endotoxemia initiates obesity and insulin resistance.
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R. Cani PD, et al. Diabetes. 2007 Jul;56(7):1761-72. doi: 10.2337/db06-1491. Epub 2007 Apr 24. Diabetes. 2007. PMID: 17456850 - Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.
Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, Corthesy I, Macé K, Chou CJ. Membrez M, et al. FASEB J. 2008 Jul;22(7):2416-26. doi: 10.1096/fj.07-102723. Epub 2008 Mar 7. FASEB J. 2008. PMID: 18326786 - Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.
Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM. Cani PD, et al. Gut. 2009 Aug;58(8):1091-103. doi: 10.1136/gut.2008.165886. Epub 2009 Feb 24. Gut. 2009. PMID: 19240062 Free PMC article. - Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
Frazier TH, DiBaise JK, McClain CJ. Frazier TH, et al. JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):14S-20S. doi: 10.1177/0148607111413772. Epub 2011 Aug 1. JPEN J Parenter Enteral Nutr. 2011. PMID: 21807932 Review. - Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.
Cani PD, Delzenne NM, Amar J, Burcelin R. Cani PD, et al. Pathol Biol (Paris). 2008 Jul;56(5):305-9. doi: 10.1016/j.patbio.2007.09.008. Epub 2008 Jan 30. Pathol Biol (Paris). 2008. PMID: 18178333 Review.
Cited by
- The role of probiotics on the roadmap to a healthy microbiota: a symposium report.
Lockyer S, Aguirre M, Durrant L, Pot B, Suzuki K. Lockyer S, et al. Gut Microbiome (Camb). 2020 Aug 26;1:e2. doi: 10.1017/gmb.2020.2. eCollection 2020. Gut Microbiome (Camb). 2020. PMID: 39296722 Free PMC article. Review. - The gut microbiota in thrombosis.
Khuu MP, Paeslack N, Dremova O, Benakis C, Kiouptsi K, Reinhardt C. Khuu MP, et al. Nat Rev Cardiol. 2024 Sep 17. doi: 10.1038/s41569-024-01070-6. Online ahead of print. Nat Rev Cardiol. 2024. PMID: 39289543 Review. - Limited support for a direct connection between prebiotics and intestinal permeability - a systematic review.
Acharya B, Tofthagen M, Maciej-Hulme ML, Suissa MR, Karlsson NG. Acharya B, et al. Glycoconj J. 2024 Sep 17. doi: 10.1007/s10719-024-10165-8. Online ahead of print. Glycoconj J. 2024. PMID: 39287885 Review. - The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease.
Hays KE, Pfaffinger JM, Ryznar R. Hays KE, et al. Gut Microbes. 2024 Jan-Dec;16(1):2393270. doi: 10.1080/19490976.2024.2393270. Epub 2024 Sep 16. Gut Microbes. 2024. PMID: 39284033 Free PMC article. Review. - Food Additives' Impact on Gut Microbiota and Metabolic Syndrome: A Systematic Review.
Singh S, Olayinka OT, Fr J, Nisar MR, Kotha R, Saad-Omer SI, Nath TS. Singh S, et al. Cureus. 2024 Aug 13;16(8):e66822. doi: 10.7759/cureus.66822. eCollection 2024 Aug. Cureus. 2024. PMID: 39280570 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous